Internal Medicine, Gastroenterology · Valparaiso, IN
NPI
1821060286
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2206 Roosevelt Rd Ste A
Valparaiso, IN, 46383
Phone (219) 464-9507
Groups this clinician bills Medicare through
Medicare paid, 2024
$159K
1,818 services
Medicare patients, 2024
969
Average age 74
Drug cost, 2024
$580K
3,530 prescriptions
Company payments, 2025
$3,322
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen H Paul was code 99214 (office e&m - established), 491 times for 373 patients. In total Stephen H Paul billed 1,818 services in 34 codes, and Medicare paid $159K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 491 | 373 | $82.86 | $41K |
| 99213 Office E&M - Established | Office | 210 | 191 | $57.72 | $12K |
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 173 | 173 | $3.65 | $631 |
| 45385 Colonoscopy - Lesion Removal | Office | 171 | 171 | $182.47 | $31K |
| 45380 Lower GI Endoscopy - Other | Office | 167 | 167 | $82.15 | $14K |
| 43239 Upper GI Endoscopy | Office | 110 | 107 | $70.99 | $7,809 |
| 99204 Office E&M - New | Office | 110 | 109 | $98.00 | $11K |
| 99203 Office E&M - New | Office | 64 | 64 | $66.91 | $4,282 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Office | 61 | 61 | $162.32 | $9,902 |
| 45384 Colonoscopy - Lesion Removal | Office | 48 | 48 | $82.61 | $3,965 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 30 | 30 | $167.79 | $5,034 |
| 45378 Lower GI Endoscopy - Other | Office | 29 | 29 | $107.19 | $3,109 |
| 45380 Lower GI Endoscopy - Other | Facility | 16 | 16 | $73.82 | $1,181 |
| 43235 Upper GI Endoscopy | Office | 16 | 16 | $76.54 | $1,225 |
| 43450 Digestive/Gastrointestinal | Office | 13 | 13 | $29.22 | $380 |
By year: 2022 $176K for 2,339 services; 2023 $179K for 2,279 services; 2024 $159K for 1,818 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stephen H Paul prescribed most often to Medicare patients was Dicyclomine Hcl, with 734 prescriptions and refills. In total Stephen H Paul wrote 3,530 Medicare prescriptions that cost $580K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dicyclomine Hcl Generic | 734 | 1,599 | 227 | $16K |
| Omeprazole Generic | 537 | 1,500 | 166 | $5,637 |
| Famotidine Generic | 259 | 630 | 74 | $2,415 |
| Pantoprazole Sodium Generic | 259 | 727 | 85 | $4,130 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 247 | 349 | 68 | $5,739 |
| Amitriptyline Hcl Generic | 163 | 349 | 45 | $1,846 |
| Esomeprazole Magnesium Generic | 160 | 445 | 49 | $7,196 |
| Sucralfate Generic | 99 | 187 | 37 | $6,212 |
| Lansoprazole Generic | 80 | 226 | 25 | $2,429 |
| Dexlansoprazole Dr Dexlansoprazole | 64 | 160 | 17 | $17K |
| Colestipol Hcl Generic | 59 | 149 | 22 | $3,397 |
| Ondansetron Odt Ondansetron | 57 | 57 | 18 | $1,341 |
| Mesalamine Generic | 56 | 152 | 15 | $80K |
| Alosetron Hcl Generic | 50 | 58 | Under 11 | $46K |
| Sulfasalazine Generic | 42 | 98 | 14 | $1,054 |
Brand drugs: 274 claims; generic drugs: 3,244 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen H Paul $3,322 ($3,322 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $625.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $625 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 18 | $438 |
| Madrigal Pharmaceuticals MDGL | 12 | $378 |
| Janssen Biotech, Inc. JNJ | 29 | $368 |
| NeurAxis, Inc. NRXS | 1 | $167 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 12 | $165 |
| Ardelyx, Inc. ARDX | 7 | $153 |
| Aimmune Therapeutics, Inc. | 7 | $145 |
| Genzyme Corporation SNY | 5 | $143 |
| QOL Medical, LLC | 6 | $102 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.